Xiaofang Pharmaceuticals (603207.SH) plans to raise funds through private placement, not exceeding 219 million yuan, for the construction of a new project at the external medicine production base.

Smart Financial News App News, Xiaofang Pharmaceutical (603207.SH) announced that the company plans to issue shares to specific investors through a simplified process. The number of specific investors will not exceed thirty-five, and the total amount of funds raised will not exceed 2.19 billion yuan. The funds raised, after deducting relevant issuance expenses, will be invested in the new construction project of the external use drug production base.